Breast Cancer Information Information Research

Digital Infrared Thermal Imaging In Medical Therapy

Digital technology now makes Digital Infrared Thermal Imaging available to all. There now is a completely safe test that can aid in diagnosis, treatment and monitoring with absolutely no risk or radiation exposure.

DITI, or digital infrared thermal imaging, is a noninvasive diagnostic test that allows a health practitioner to see and measure changes in skin surface temperature. An infrared scanning camera translates infrared radiation emitted from the skin surface and records them on a color monitor. This visual image graphically maps the body temperature and is referred to as a thermogram. The spectrum of colors indicates an increase or decrease in the amount of infrared radiation being emitted from the body surface. In healthy people, there is a symmetrical skin pattern which is consistent and reproducible for any individual.

DITI is highly sensitive and can therefore be used clinically to detect disease in the vascular, muscular, neural and skeletal systems. Medical DITI has been used extensively in human medicine in the United States, Europe and Asia for the past 20 years. Until now, bulky equipment has hindered its diagnostic and economic feasibility. Now, PC-based infrared technology designed specifically for clinical application has changed all this.

Clinical uses for DITI include, defining the extent of a lesion of which a diagnosis has previously been made (for example, vascular disease); localizing an abnormal area not previously identified, so further diagnostic tests can be performed (as in Irritable Bowel Syndrome); detecting early lesions before they are clinically evident (as in breast cancer or other breast diseases); and monitoring the healing process before a patient returns to work or training (as in workman's compensation claims).

Medical DITI is filling the gap in clinical diagnosis; X-ray, Computed Tomography, Ultrasound and Magnetic Resonance Imaging (MRI), are tests of anatomy or structure. DITI is unique in its capability to show physiological or functional changes and metabolic processes. It has also proven to be a very useful complementary procedure to other diagnostic procedures.

Unlike most diagnostic modalities DITI is non invasive. It is a very sensitive and reliable means of graphically mapping and displaying skin surface temperature. With DITI you can diagnosis, evaluate, monitor and document a large number of injuries and conditions, including soft tissue injuries and sensory/autonomic nerve fiber dysfunction. Medical DITI can offer considerable financial savings by avoiding the need for more expensive investigation for many patients. Medical DITI can graphically display the biased feeling of pain by accurately displaying the changes in skin surface temperature. Disease states commonly associated with pain include Reflex Sympathetic Dystrophy or RSD, Fibromyalgia and Rheumatoid arthritis.

Medical DITI can show a combined effect of the autonomic nervous system and the vascular system, down to capillary dysfunctions. The effects of these changes reveal an asymmetry in temperature distribution on the surface of the body. DITI is a monitor of thermal abnormalities present in a number of diseases and physical injuries. It is used as an aid for diagnosis and prognosis, as well as therapy follow up and rehabilitation monitoring, within clinical fields that include rheumatology, neurology, physiotherapy, sports medicine, oncology, pediatrics, orthopedics and many others.

Results obtained with medical DITI systems are totally objective and show excellent correlation with other diagnostic tests.

Thermographic screening is not covered by most insurance companies but is surprisingly affordable for most people. For more information or to find a certified clinic in your area, go to

Brenda Witt is co-owner of Proactive Health Solutions in Southern California. She is an American College of Clinical Thermology (ACCT) certified thermographer in the Orange County area.


People Magazine

See Disney Princesses and Other Cartoons Reimagined as Breast Cancer ...
People Magazine
In an art series titled Survivor, contemporary artist Alexsandro Palombo created graphics of iconic female cartoon characters visualized as survivors of breast cancer in order to raise awareness and educate younger generations about the life ...
Artist AleXsandro Palombo Shows What Disney Princesses Would Look Like As ...Medical Daily

all 3 news articles »

Huffington Post

Stunning Book Of Portraits Shows 'Beauty After Breast Cancer'
Huffington Post
Carey, a nurse and mother of two, has a family history of breast cancer and underwent a preventative mastectomy at the age of 29. Inspired by her experience, she is creating Beauty After Breast Cancer, a book of portraits and narratives that explains ...
Breast Cancer Patients Should Consider Reconstruction Using FatPhysicians News Digest

all 3 news articles »

Science Times

Boning Up Against Breast Cancer: How It Can Alter Its Structure to Help It Spread
Science Times
A team of scientists from the University of Sheffield and University of Copenhagen have discovered an enzyme which helps breast cancer spread, and in the process, have found a possible way to prevent the spread of breast cancer-secondary or metastatic ...
Breast Cancer: Key to Preventing Secondary Cancers IdentifiedNature World News
Scientific discovery may stop breast cancer spreading to the bonesMedical News Today
Share “Breast cancer could be 'stopped in its...”
Elite Daily (blog) -Empire State Tribune
all 88 news articles »

“My Unborn Baby Saved My Life:” Pregnancy Helps Mom Discover Breast Cancer
In the United Kingdom, 33-year-old Seema Tailor-Bulsara was diagnosed with breast cancer when she was five months pregnant with her son, Jai. Initially, Seema thought the lump on her left breast was a blocked milk duck but went to have it examined ...

Medical Xpress

One in five women with breast cancer don't know about test results that might ...
Medical Xpress
Although 90 percent of women with early-stage breast cancer said they were aware they took a genomic test that identified their level of risk for a recurrence of the disease, one in five didn't know the results of that analysis, according to a new fact ...


Local women join others in national walk to end breast cancer
MASON CITY, Iowa – Three local women will be making the trek to Chicago, as they hope to stamp out breast cancer one mile at a time. Tasha Ellis, Justine Gerber and Bobbie Prigge will be participating in the Avon 39 walk to end breast cancer. The two ...

UCLA Newsroom

1 in 5 women with breast cancer don't know about test results that might help ...
UCLA Newsroom
Although 90 percent of women with early-stage breast cancer said they were aware they took a genomic test that identified their level of risk for a recurrence of the disease, 1 in 5 didn't know the results of that analysis, according to a new fact ...
New Study Helps Increase Personalized Care for Breast Cancer PatientsGlobeNewswire (press release)
Now breast cancer patients can avoid chemo?TheHealthSite
New gene test to help some breast cancer patients avoid chemoNew Kerala
The Asian Age
all 12 news articles »

Fox News

Family history may not impact breast cancer survival odds
Fox News
Worldwide, breast cancer is the most common malignancy in women. About one in nine women will eventually develop it, according to the U.S. National Institutes of Health. The risk increases with age, from one in 227 at age 30 to one in 26 by age 70.
Family history may not worsen the odds of survival for breast cancer patientsBusiness Insider

all 10 news articles »

Researchers question genetic tests for breast cancer
Researchers questioned genetic tests which look for mutated genes that may increase risk of breast cancer. Many of the tests review more than 100 genes, while only 21 of them have been found to be indicative of potentially developing breast cancer, ...
Tests for Multiple Genes for Breast Cancer May Not Be ValidYouth Health Magzine
Dozens of Genes in Breast Cancer Tests Have Tenuous Link to RiskBloomberg
Breast cancer genetic tests without clinical validity should not be offered ...Genetic Literacy Project
NYC Today -West Texas News -San Diego Source (subscription)
all 38 news articles »

Puma Bio Restricting Access to Breast Cancer Event at ASCO Chicago
LOS ANGELES (TheStreet) -- Chicago is the city of big shoulders, but not of sufficiently large hotel conference rooms, says Puma Biotechnology (PBYI). Puma Bio, embroiled in controversy over its breast cancer drug neratinib, is turning away some ...

and more »

Google News


home | site map
© 2006